Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets

A Fodor, B Tiperciuc, C Login… - Oxidative medicine …, 2021 - Wiley Online Library
The outbreak of the COVID‐19 pandemic represents an ongoing healthcare emergency
responsible for more than 3.4 million deaths worldwide. COVID‐19 is the disease caused by …

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition

Y Luo, M Alexander, M Gadina, JJ O'Shea… - Journal of Allergy and …, 2021 - Elsevier
Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK-
STAT) pathway has become recognized as a central mediator of widespread and varied …

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression

SK Dhar, K Vishnupriyan, S Damodar, S Gujar, M Das - Heliyon, 2021 - cell.com
Abstract Aims SARS-CoV-2, an infectious agent behind the ongoing COVID-19 pandemic,
induces high levels of cytokines such as IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ etc in …

[HTML][HTML] Biomarkers for prognosis and treatment response in COVID-19 patients

G Bivona, L Agnello, M Ciaccio - Annals of laboratory …, 2021 - synapse.koreamed.org
During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …

Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation

P Keshavarz, F Rafiee, H Kavandi, S Goudarzi… - Clinical imaging, 2021 - Elsevier
Background Limited data is available addressing gastrointestinal (GI) ischemia in
coronavirus disease 2019 (COVID-19). We reviewed the clinical and radiologic features of …

[HTML][HTML] Metabolic syndrome and COVID-19

H Yanai - Cardiology research, 2020 - ncbi.nlm.nih.gov
Recent studies showed that comorbidities such as diabetes, hypertension and obesity
contribute to severe and worse outcomes of coronavirus disease 2019 (COVID-19) …

The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis

AF Almulla, T Supasitthumrong… - BMC Infectious …, 2022 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is accompanied by activated
immune-inflammatory pathways and oxidative stress, which both induce indoleamine-2, 3 …

The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study

A Tanacan, N Yazihan, SA Erol, AT Anuk, FDY Yetiskin… - Cytokine, 2021 - Elsevier
Objective To compare the levels of various cytokines between pregnant women with
confirmed coronavirus disease (COVID-19) infection and pregnant women without any …

IL-4/IL-13 remodeling pathway of COVID-19 lung injury

CB Vaz de Paula, MLV de Azevedo, S Nagashima… - Scientific Reports, 2020 - nature.com
The COVID-19 fatality rate is high when compared to the H1N1pdm09 (pandemic Influenza
A virus H1N1 subtype) rate, and although both cause an aggravated inflammatory response …

[HTML][HTML] Nitazoxanide superiority to placebo to treat moderate COVID-19–A Pilot prove of concept randomized double-blind clinical trial.

VF Blum, S Cimerman, JR Hunter, P Tierno… - …, 2021 - thelancet.com
Background The absence of specific antivirals to treat COVID-19 leads to the repositioning
of candidates' drugs. Nitazoxanide (NTZ) has a broad antiviral effect. Methods This was a …